218 related articles for article (PubMed ID: 24133212)
1. A soluble fragment of the tumor antigen BCL2-associated athanogene 6 (BAG-6) is essential and sufficient for inhibition of NKp30 receptor-dependent cytotoxicity of natural killer cells.
Binici J; Hartmann J; Herrmann J; Schreiber C; Beyer S; Güler G; Vogel V; Tumulka F; Abele R; Mäntele W; Koch J
J Biol Chem; 2013 Nov; 288(48):34295-303. PubMed ID: 24133212
[TBL] [Abstract][Full Text] [Related]
2. Secreted Ligands of the NK Cell Receptor NKp30: B7-H6 Is in Contrast to BAG6 Only Marginally Released via Extracellular Vesicles.
Ponath V; Hoffmann N; Bergmann L; Mäder C; Alashkar Alhamwe B; Preußer C; Pogge von Strandmann E
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671836
[TBL] [Abstract][Full Text] [Related]
3. Homo-oligomerization of the activating natural killer cell receptor NKp30 ectodomain increases its binding affinity for cellular ligands.
Herrmann J; Berberich H; Hartmann J; Beyer S; Davies K; Koch J
J Biol Chem; 2014 Jan; 289(2):765-77. PubMed ID: 24275655
[TBL] [Abstract][Full Text] [Related]
4. BAG-6, a jack of all trades in health and disease.
Binici J; Koch J
Cell Mol Life Sci; 2014 May; 71(10):1829-37. PubMed ID: 24305946
[TBL] [Abstract][Full Text] [Related]
5. Human leukocyte antigen-B-associated transcript 3 is released from tumor cells and engages the NKp30 receptor on natural killer cells.
Pogge von Strandmann E; Simhadri VR; von Tresckow B; Sasse S; Reiners KS; Hansen HP; Rothe A; Böll B; Simhadri VL; Borchmann P; McKinnon PJ; Hallek M; Engert A
Immunity; 2007 Dec; 27(6):965-74. PubMed ID: 18055229
[TBL] [Abstract][Full Text] [Related]
6. B7-H6/NKp30 interaction: a mechanism of alerting NK cells against tumors.
Kaifu T; Escalière B; Gastinel LN; Vivier E; Baratin M
Cell Mol Life Sci; 2011 Nov; 68(21):3531-9. PubMed ID: 21877119
[TBL] [Abstract][Full Text] [Related]
7. Important role for NKp30 in synapse formation and activation of NK cells.
Wang H; Zheng X; Wei H; Tian Z; Sun R
Immunol Invest; 2012; 41(4):367-81. PubMed ID: 22221078
[TBL] [Abstract][Full Text] [Related]
8. Expression, crystallization and X-ray diffraction analysis of a complex between B7-H6, a tumor cell ligand for the natural cytotoxicity receptor NKp30, and an inhibitory antibody.
Xu X; Li Y; Gauthier L; Chen Q; Vivier E; Mariuzza RA
Acta Crystallogr F Struct Biol Commun; 2015 Jun; 71(Pt 6):697-701. PubMed ID: 26057798
[TBL] [Abstract][Full Text] [Related]
9. The stalk domain and the glycosylation status of the activating natural killer cell receptor NKp30 are important for ligand binding.
Hartmann J; Tran TV; Kaudeer J; Oberle K; Herrmann J; Quagliano I; Abel T; Cohnen A; Gatterdam V; Jacobs A; Wollscheid B; Tampé R; Watzl C; Diefenbach A; Koch J
J Biol Chem; 2012 Sep; 287(37):31527-39. PubMed ID: 22807449
[TBL] [Abstract][Full Text] [Related]
10. Modulation of NKp30- and NKp46-mediated natural killer cell responses by poxviral hemagglutinin.
Jarahian M; Fiedler M; Cohnen A; Djandji D; Hämmerling GJ; Gati C; Cerwenka A; Turner PC; Moyer RW; Watzl C; Hengel H; Momburg F
PLoS Pathog; 2011 Aug; 7(8):e1002195. PubMed ID: 21901096
[TBL] [Abstract][Full Text] [Related]
11. Tumor-released Galectin-3, a soluble inhibitory ligand of human NKp30, plays an important role in tumor escape from NK cell attack.
Wang W; Guo H; Geng J; Zheng X; Wei H; Sun R; Tian Z
J Biol Chem; 2014 Nov; 289(48):33311-9. PubMed ID: 25315772
[TBL] [Abstract][Full Text] [Related]
12. Affinity Maturation of B7-H6 Translates into Enhanced NK Cell-Mediated Tumor Cell Lysis and Improved Proinflammatory Cytokine Release of Bispecific Immunoligands via NKp30 Engagement.
Pekar L; Klausz K; Busch M; Valldorf B; Kolmar H; Wesch D; Oberg HH; Krohn S; Boje AS; Gehlert CL; Toleikis L; Krah S; Gupta T; Rabinovich B; Zielonka S; Peipp M
J Immunol; 2021 Jan; 206(1):225-236. PubMed ID: 33268483
[TBL] [Abstract][Full Text] [Related]
13. Activating natural cytotoxicity receptors of natural killer cells in cancer and infection.
Koch J; Steinle A; Watzl C; Mandelboim O
Trends Immunol; 2013 Apr; 34(4):182-91. PubMed ID: 23414611
[TBL] [Abstract][Full Text] [Related]
14. The Natural Cytotoxicity Receptors in Health and Disease.
Barrow AD; Martin CJ; Colonna M
Front Immunol; 2019; 10():909. PubMed ID: 31134055
[TBL] [Abstract][Full Text] [Related]
15. Functional capacity of natural killer cells in HTLV-1 associated myelopathy/tropical spastic paraparesis (HAM/TSP) patients.
Queiroz GAN; Mascarenhas REM; Vieillard V; Andrade RL; Galvão-Castro B; Grassi MFR
BMC Infect Dis; 2019 May; 19(1):433. PubMed ID: 31101076
[TBL] [Abstract][Full Text] [Related]
16. PET Imaging of the Natural Killer Cell Activation Receptor NKp30.
Shaffer TM; Aalipour A; Schürch CM; Gambhir SS
J Nucl Med; 2020 Sep; 61(9):1348-1354. PubMed ID: 32532927
[TBL] [Abstract][Full Text] [Related]
17. Interleukin-2 is required for NKp30-dependent NK cell cytotoxicity by preferentially regulating NKp30 expression.
Kim N; Yi E; Lee E; Park HJ; Kim HS
Front Immunol; 2024; 15():1388018. PubMed ID: 38698855
[TBL] [Abstract][Full Text] [Related]
18. Mimicking an induced self phenotype by coating lymphomas with the NKp30 ligand B7-H6 promotes NK cell cytotoxicity.
Kellner C; Maurer T; Hallack D; Repp R; van de Winkel JG; Parren PW; Valerius T; Humpe A; Gramatzki M; Peipp M
J Immunol; 2012 Nov; 189(10):5037-46. PubMed ID: 23066150
[TBL] [Abstract][Full Text] [Related]
19. Dual-functional capability of CD3+CD56+ CIK cells, a T-cell subset that acquires NK function and retains TCR-mediated specific cytotoxicity.
Pievani A; Borleri G; Pende D; Moretta L; Rambaldi A; Golay J; Introna M
Blood; 2011 Sep; 118(12):3301-10. PubMed ID: 21821703
[TBL] [Abstract][Full Text] [Related]
20. Reconstitution of a ligand-binding competent murine NKp30 receptor.
Memmer S; Weil S; Koch J
Immunogenetics; 2018 Mar; 70(3):185-194. PubMed ID: 28782088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
